Do stem cells in the heart truly differentiate into cardiomyocytes?

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 4, 2007, Pages 377-387

  Guan, Kaomei ^a   Hasenfuss, Gerd ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cardiac regeneration; Heart failure; Stem cell

Indexed keywords

ATAXIN 1; STEM CELL FACTOR;

CELL DIFFERENTIATION; CELL REGENERATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; ENDOTHELIUM; HOMEODOMAIN PROTEINS; HUMANS; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; SPERMATOGONIA; SPHEROIDS, CELLULAR; STEM CELLS;

EID: 34548846364     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.07.056     Document Type: Review

References (120)

1. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
2. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 7634-7638
3. Guan K., Furst D.O., and Wobus A.M. Modulation of sarcomere organization during embryonic stem cell-derived cardiomyocyte differentiation. Eur. J. Cell Biol. 78 (1999) 813-823
4. Westfall M.V., Pasyk K.A., Yule D.I., Samuelson L.C., and Metzger J.M. Ultrastructure and cell-cell coupling of cardiac myocytes differentiating in embryonic stem cell cultures. Cell Motil. Cytoskeleton 36 (1997) 43-54
5. Wei H., Juhasz O., Li J., Tarasova Y.S., and Boheler K.R. Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. J. Cell. Mol. Med. 9 (2005) 804-817
6. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
7. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108 (2001) 407-414
8. Xu C., Police S., Rao N., and Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 91 (2002) 501-508
9. He J.Q., Ma Y., Lee Y., Thomson J.A., and Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93 (2003) 32-39
10. Reppel M., Boettinger C., and Hescheler J. Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. 14 (2004) 187-196
11. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22 (2004) 1282-1289
12. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 (2005) 11-20
13. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167 (2005) 663-671
14. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., and Langer R. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4391-4396
15. Singla D.K., Hacker T.A., Ma L., Douglas P.S., Sullivan R., Lyons G.E., et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J. Mol. Cell. Cardiol. 40 (2006) 195-200
16. Behfar A., Zingman L.V., Hodgson D.M., Rauzier J.M., Kane G.C., Terzic A., et al. Stem cell differentiation requires a paracrine pathway in the heart. Faseb J. 16 (2002) 1558-1566
17. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Physiol.: Heart Circ. Physiol. 287 (2004) H471-H479
18. Min J.Y., Yang Y., Converso K.L., Liu L., Huang Q., Morgan J.P., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92 (2002) 288-296
19. Klug M.G., Soonpaa M.H., Koh G.Y., and Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98 (1996) 216-224
20. Capi O., and Gepstein L. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. J. Control. Release 116 (2006) 211-218
21. Goh G., Self T., Barbadillo Munoz M.D., Hall I.P., Young L., and Denning C. Molecular and phenotypic analyses of human embryonic stem cell-derived cardiomyocytes: opportunities and challenges for clinical translation. Thromb. Haemost. 94 (2005) 728-737
22. Zandstra P.W., Bauwens C., Yin T., Liu Q., Schiller H., Zweigerdt R., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng. 9 (2003) 767-778
23. Zhang Y.M., Hartzell C., Narlow M., and Dudley Jr. S.C. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation 106 (2002) 1294-1299
24. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
25. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12313-12318
26. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95 (2004) 911-921
27. Martin C.M., Meeson A.P., Robertson S.M., Hawke T.J., Richardson J.A., Bates S., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265 (2004) 262-275
28. Linke A., Muller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8966-8971
29. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
30. Dawn B., Stein A.B., Urbanek K., Rota M., Whang B., Rastaldo R., et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3766-3771
31. Urbanek K., Quaini F., Tasca G., Torella D., Castaldo C., Nadal-Ginard B., et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10440-10445
32. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8692-8697
33. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
34. Pfister O., Mouquet F., Jain M., Summer R., Helmes M., Fine A., et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res. 97 (2005) 52-61
35. Wang X., Hu Q., Nakamura Y., Lee J., Zhang G., From A.H., et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 24 (2006) 1779-1788
36. Mouquet F., Pfister O., Jain M., Oikonomopoulos A., Ngoy S., Summer R., et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ. Res. 97 (2005) 1090-1092
37. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 (2006) 1151-1165
38. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
39. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. N. Engl. J. Med. 346 (2002) 5-15
40. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
41. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
42. LaBarge M.A., and Blau H.M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111 (2002) 589-601
43. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6 (2000) 1229-1234
44. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10711-10716
45. Mezey E., Chandross K.J., Harta G., Maki R.A., and McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 (2000) 1779-1782
46. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (2000) 1775-1779
47. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
48. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107 (2001) 1395-1402
49. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
50. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
51. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 96 (2005) 127-137
52. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
53. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
54. Nygren J.M., Jovinge S., Breitbach M., Sawen P., Roll W., Hescheler J., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10 (2004) 494-501
55. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
56. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
57. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103 (1999) 697-705
58. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100 (1999) II247-II256
59. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
60. Wang J.S., Shum-Tim D., Galipeau J., Chedrawy E., Eliopoulos N., and Chiu R.C. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120 (2000) 999-1005
61. Shake J.G., Gruber P.J., Baumgartner W.A., Senechal G., Meyers J., Redmond J.M., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73 (2002) 1919-1925 [discussion 1926]
62. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., and Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363 (2004) 783-784
63. Yoon Y.S., Park J.S., Tkebuchava T., Luedeman C., and Losordo D.W. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109 (2004) 3154-3157
64. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
65. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438
66. Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 (2000) 3106-3112
67. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
68. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105 (2000) 1527-1536
69. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
70. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
71. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
72. Kawamoto A., Tkebuchava T., Yamaguchi J., Nishimura H., Yoon Y.S., Milliken C., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
73. Iwasaki H., Kawamoto A., Ishikawa M., Oyamada A., Nakamori S., Nishimura H., et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113 (2006) 1311-1325
74. Condorelli G., Borello U., De Angelis L., Latronico M., Sirabella D., Coletta M., et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10733-10738
75. Badorff C., Brandes R.P., Popp R., Rupp S., Urbich C., Aicher A., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
76. Koyanagi M., Urbich C., Chavakis E., Hoffmann J., Rupp S., Badorff C., et al. Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin. FEBS Lett. 579 (2005) 6060-6066
77. Gruh I., Beilner J., Blomer U., Schmiedl A., Schmidt-Richter I., Kruse M.L., et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113 (2006) 1326-1334
78. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
79. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115 (2005) 326-338
80. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
81. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
82. Fernandez-Aviles F., San Roman J.A., Garcia-Frade J., Fernandez M.E., Penarrubia M.J., de la Fuente L., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95 (2004) 742-748
83. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
84. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., and Forfang K. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand. Cardiovasc. J. 39 (2005) 150-158
85. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
86. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
87. Zohlnhofer D., Ott I., Mehilli J., Schomig K., Michalk F., Ibrahim T., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295 (2006) 1003-1010
88. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
89. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355 (2006) 1222-1232
90. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1199-1209
91. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur. Heart J. 27 (2006) 2775-2783
92. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
93. Patel A.N., Geffner L., Vina R.F., Saslavsky J., Urschel Jr. H.C., Kormos R., et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J. Thorac. Cardiovasc. Surg. 130 (2005) 1631-1638
94. Fuchs S., Satler L.F., Kornowski R., Okubagzi P., Weisz G., Baffour R., et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J. Am. Coll. Cardiol. 41 (2003) 1721-1724
95. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
96. Tse H.F., Kwong Y.L., Chan J.K., Lo G., Ho C.L., and Lau C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
97. Cleland J.G., Freemantle N., Coletta A.P., and Clark A.L. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur. J. Heart Fail. 8 (2006) 105-110
98. Wollert K.C., and Drexler H. Cell-based therapy for heart failure. Curr. Opin. Cardiol. 21 (2006) 234-239
99. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10344-10349
100. Fazel S., Cimini M., Chen L., Li S., Angoulvant D., Fedak P., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116 (2006) 1865-1877
101. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94 (2004) 678-685
102. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353 (2005) 999-1007
103. Guan K., Nayernia K., Maier L.S., Wagner S., Dressel R., Lee J.H., et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440 (2006) 1199-1203
104. Matsui Y., Zsebo K., and Hogan B.L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70 (1992) 841-847
105. Resnick J.L., Bixler L.S., Cheng L., and Donovan P.J. Long-term proliferation of mouse primordial germ cells in culture. Nature 359 (1992) 550-551
106. Shamblott M.J., Axelman J., Wang S., Bugg E.M., Littlefield J.W., Donovan P.J., et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13726-13731
107. Kanatsu-Shinohara M., Inoue K., Lee J., Yoshimoto M., Ogonuki N., Miki H., et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119 (2004) 1001-1012
108. Kubota H., Avarbock M.R., and Brinster R.L. Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16489-16494
109. Guan K., Wagner S., Unsold B., Maier L.S., Kaiser D., Hemmerlein B., et al. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ. Res. 100 (2007) 1615-1625
110. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
111. Menasche P. Skeletal myoblast for cell therapy. Coron. Artery Dis. 16 (2005) 105-110
112. Reinecke H., Poppa V., and Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34 (2002) 241-249
113. Reinecke H., MacDonald G.H., Hauschka S.D., and Murry C.E. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell Biol. 149 (2000) 731-740
114. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4 (1998) 929-933
115. Scorsin M., Hagege A., Vilquin J.T., Fiszman M., Marotte F., Samuel J.L., et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J. Thorac. Cardiovasc. Surg. 119 (2000) 1169-1175
116. Leobon B., Garcin I., Menasche P., Vilquin J.T., Audinat E., and Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7808-7811
117. Abraham M.R., Henrikson C.A., Tung L., Chang M.G., Aon M., Xue T., et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 97 (2005) 159-167
118. Murtuza B., Suzuki K., Bou-Gharios G., Beauchamp J.R., Smolenski R.T., Partridge T.A., et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 4216-4221
119. Reinecke H., Minami E., Poppa V., and Murry C.E. Evidence for fusion between cardiac and skeletal muscle cells. Circ. Res. 94 (2004) e56-e60
120. Winitsky S.O., Gopal T.V., Hassanzadeh S., Takahashi H., Gryder D., Rogawski M.A., et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol. 3 (2005) e87